Nayra Pérez‐Delgado

622 total citations
20 papers, 381 citations indexed

About

Nayra Pérez‐Delgado is a scholar working on Nephrology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Nayra Pérez‐Delgado has authored 20 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Nephrology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Nayra Pérez‐Delgado's work include Parathyroid Disorders and Treatments (14 papers), Chronic Kidney Disease and Diabetes (6 papers) and Genetic Syndromes and Imprinting (4 papers). Nayra Pérez‐Delgado is often cited by papers focused on Parathyroid Disorders and Treatments (14 papers), Chronic Kidney Disease and Diabetes (6 papers) and Genetic Syndromes and Imprinting (4 papers). Nayra Pérez‐Delgado collaborates with scholars based in Spain. Nayra Pérez‐Delgado's co-authors include Javier Donate‐Correa, Carmen Mora‐Fernández, Juan F. Navarro‐González, Ernesto Martín‐Núñez, Carla Ferri, Alberto Ortíz, Carolina Hernández-Carballo, Sergio Rodriguez, María Dolores Sánchez-Niño and Víctor G. Tagua and has published in prestigious journals such as Diabetes Care, Scientific Reports and Transplantation.

In The Last Decade

Nayra Pérez‐Delgado

20 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nayra Pérez‐Delgado Spain 11 259 110 84 70 47 20 381
Yoko Kikumoto Japan 11 238 0.9× 74 0.7× 58 0.7× 74 1.1× 29 0.6× 12 362
Annelies De Maré Belgium 8 193 0.7× 60 0.5× 162 1.9× 45 0.6× 51 1.1× 9 407
Rebecca McCrery United States 12 287 1.1× 80 0.7× 116 1.4× 166 2.4× 36 0.8× 30 592
Toru Kagawa Japan 7 184 0.7× 67 0.6× 81 1.0× 74 1.1× 61 1.3× 9 361
Candace Crasto United States 7 355 1.4× 174 1.6× 113 1.3× 69 1.0× 40 0.9× 8 491
Akihiro Shimomura Japan 10 219 0.8× 43 0.4× 114 1.4× 47 0.7× 27 0.6× 22 415
F. Kirchhoff Germany 6 203 0.8× 76 0.7× 94 1.1× 70 1.0× 24 0.5× 7 314
Ji Gao China 5 107 0.4× 48 0.4× 69 0.8× 77 1.1× 78 1.7× 6 260
Hai-Ying Qi China 6 157 0.6× 41 0.4× 168 2.0× 48 0.7× 53 1.1× 12 403
P. Manghat United Kingdom 7 264 1.0× 69 0.6× 56 0.7× 51 0.7× 29 0.6× 8 371

Countries citing papers authored by Nayra Pérez‐Delgado

Since Specialization
Citations

This map shows the geographic impact of Nayra Pérez‐Delgado's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nayra Pérez‐Delgado with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nayra Pérez‐Delgado more than expected).

Fields of papers citing papers by Nayra Pérez‐Delgado

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nayra Pérez‐Delgado. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nayra Pérez‐Delgado. The network helps show where Nayra Pérez‐Delgado may publish in the future.

Co-authorship network of co-authors of Nayra Pérez‐Delgado

This figure shows the co-authorship network connecting the top 25 collaborators of Nayra Pérez‐Delgado. A scholar is included among the top collaborators of Nayra Pérez‐Delgado based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nayra Pérez‐Delgado. Nayra Pérez‐Delgado is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Donate‐Correa, Javier, et al.. (2024). Pentoxifylline ameliorates subclinical atherosclerosis progression in patients with type 2 diabetes and chronic kidney disease: a randomized pilot trial. Cardiovascular Diabetology. 23(1). 314–314. 8 indexed citations
2.
Donate‐Correa, Javier, Ernesto Martín‐Núñez, Carmen Mora‐Fernández, et al.. (2023). Klotho inversely relates with carotid intima- media thickness in atherosclerotic patients with normal renal function (eGFR ≥60 mL/min/1.73m2): a proof-of-concept study. Frontiers in Endocrinology. 14. 1146012–1146012. 4 indexed citations
3.
Mora‐Fernández, Carmen, María Dolores Sánchez-Niño, Javier Donate‐Correa, et al.. (2022). Sodium-glucose co-transporter-2 inhibitors increase Klotho in patients with diabetic kidney disease: A clinical and experimental study. Biomedicine & Pharmacotherapy. 154. 113677–113677. 30 indexed citations
4.
Martín‐Núñez, Ernesto, Víctor G. Tagua, Carolina Hernández-Carballo, et al.. (2022). Klotho expression in peripheral blood circulating cells is associated with vascular and systemic inflammation in atherosclerotic vascular disease. Scientific Reports. 12(1). 8422–8422. 33 indexed citations
5.
Navarro‐González, Juan F., María Dolores Sánchez-Niño, Nayra Pérez‐Delgado, et al.. (2022). MO640: Treatment with Sodium–Glucose Cotransporter 2 Inhibitors Increases Klotho in Type 2 Diabetic Patients. Nephrology Dialysis Transplantation. 37(Supplement_3). 1 indexed citations
6.
Donate‐Correa, Javier, Carla Ferri, Ernesto Martín‐Núñez, et al.. (2021). Klotho as a biomarker of subclinical atherosclerosis in patients with moderate to severe chronic kidney disease. Scientific Reports. 11(1). 15877–15877. 25 indexed citations
7.
Ferri, Carla, et al.. (2021). KLOTHO as a biomarker of subclinical cardiovascular disease in chronic kidney disease: A proof-of-concept study. Atherosclerosis. 331. e237–e237. 1 indexed citations
8.
Navarro‐González, Juan F., Carla Ferri, Ernesto Martín‐Núñez, et al.. (2020). P1008THERAPY WITH SODIUM-GLUCOSE COTRANSPORTER TYPE 2 INHIBITORS INCREASES KLOTHO IN TYPE 2 DIABETIC PATIENTS. Nephrology Dialysis Transplantation. 35(Supplement_3). 2 indexed citations
9.
Martín‐Núñez, Ernesto, Javier Donate‐Correa, Carla Ferri, et al.. (2020). Association between serum levels of Klotho and inflammatory cytokines in cardiovascular disease: a case-control study. Aging. 12(2). 1952–1964. 44 indexed citations
10.
Donate‐Correa, Javier, Ernesto Martín‐Núñez, Carolina Hernández-Carballo, et al.. (2019). Fibroblast growth factor 23 expression in human calcified vascular tissues. Aging. 11(18). 7899–7913. 18 indexed citations
11.
Donate‐Correa, Javier, Ernesto Martín‐Núñez, Carla Ferri, et al.. (2019). FGF23 and Klotho Levels are Independently Associated with Diabetic Foot Syndrome in Type 2 Diabetes Mellitus. Journal of Clinical Medicine. 8(4). 448–448. 14 indexed citations
12.
Llanos, José Pablo Suárez, et al.. (2018). Optimización del cribado nutricional CIPA: ¿son necesarios dos parámetros proteicos?. Nutrición Hospitalaria. 35(4). 914–914. 4 indexed citations
13.
Núñez, Ernesto Martín, Javier Donate‐Correa, Nayra Pérez‐Delgado, et al.. (2018). SuO024ACID URIC LEVEL AND PRO INFLAMMATORY CYTOKINES IN A COMMUNITY POPULATION. Nephrology Dialysis Transplantation. 33(suppl_1). i626–i626. 1 indexed citations
14.
Navarro‐González, Juan F., María Dolores Sánchez-Niño, Javier Donate‐Correa, et al.. (2018). Effects of Pentoxifylline on Soluble Klotho Concentrations and Renal Tubular Cell Expression in Diabetic Kidney Disease. Diabetes Care. 41(8). 1817–1820. 67 indexed citations
15.
Donate‐Correa, Javier, Fernando Henríquez, Ernesto Martín‐Núñez, et al.. (2017). Perfil antiinflamatorio del paricalcitol en el receptor de trasplante renal. Nefrología. 37(6). 622–629. 4 indexed citations
16.
Martín‐Núñez, Ernesto, Javier Donate‐Correa, Carla Ferri, et al.. (2017). Soluble levels and endogenous vascular gene expression of KLOTHO are related to inflammation in human atherosclerotic disease. Clinical Science. 131(21). 2601–2609. 40 indexed citations
17.
Donate‐Correa, Javier, Fernando Henríquez, Ernesto Martín‐Núñez, et al.. (2017). Anti-inflammatory profile of paricalcitol in kidney transplant recipients. Nefrología (English Edition). 37(6). 622–629. 2 indexed citations
18.
Donate‐Correa, Javier, Fernando Henríquez, Ernesto Martín‐Núñez, et al.. (2016). Effect of Paricalcitol on FGF-23 and Klotho in Kidney Transplant Recipients. Transplantation. 100(11). 2432–2438. 13 indexed citations
19.
Donate‐Correa, Javier, Ernesto Martín‐Núñez, Nayra Pérez‐Delgado, et al.. (2015). Implications of Fibroblast growth factor/Klotho system in glucose metabolism and diabetes. Cytokine & Growth Factor Reviews. 28. 71–77. 36 indexed citations
20.
Donate‐Correa, Javier, Ernesto Martín‐Núñez, Rafael Martínez‐Sanz, et al.. (2015). Influence of Klotho gene polymorphisms on vascular gene expression and its relationship to cardiovascular disease. Journal of Cellular and Molecular Medicine. 20(1). 128–133. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yoko Kikumoto Breakdown of academic impact, for papers by Annelies De Maré Breakdown of academic impact, for papers by Rebecca McCrery Breakdown of academic impact, for papers by Toru Kagawa Breakdown of academic impact, for papers by Candace Crasto Breakdown of academic impact, for papers by Akihiro Shimomura Breakdown of academic impact, for papers by F. Kirchhoff Breakdown of academic impact, for papers by Ji Gao Breakdown of academic impact, for papers by Hai-Ying Qi Breakdown of academic impact, for papers by P. Manghat
Rankless by CCL
2026